Product Information
ACID REDUCER 20 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.1382 per EA under NDC 70000071001. Its NADAC has been published 62 times since Jul 30, 2025.
FDA first approved this application on May 28, 2024.
Strength
20 mg/1
Manufacturer
Cardinal HealthNDC
70000071001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA218003FDA Approved
5/28/2024
On Market Since
12/4/2024
Pharmacological Classes
Price Statistics
The NADAC for ACID REDUCER 20 MG TABLET has been published 62 times since Jul 30, 2025, and over the history we have for it it has declined 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1480 (Dec 10, 2025) |
| All-time low | $0.1382 (Sep 23, 2026) |
| 52-week high | $0.1480 |
| 52-week low | $0.1382 |
| Median price | $0.1452 |
| Average price | $0.1447 |
| Largest weekly change | +3.8% (Sep 17, 2025) |
| Weeks tracked | 62 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 25 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACID REDUCER 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACID REDUCER 20 MG TABLET, manufactured by Cardinal Health, is $0.1382 per EA (NDC 70000071001), effective Sep 30, 2026.
How has the price of ACID REDUCER 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACID REDUCER 20 MG TABLET has declined 5.3%. It has been tracked across 62 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for ACID REDUCER 20 MG TABLET?
Since Jul 30, 2025, the NADAC for ACID REDUCER 20 MG TABLET has ranged from a low of $0.1382 (Sep 23, 2026) to a high of $0.1480 (Dec 10, 2025), with a median of $0.1452 per EA.
Are there cheaper alternatives to ACID REDUCER 20 MG TABLET?
Yes. 25 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 20 MG TABLET, is $0.0289 per EA — about 79% below ACID REDUCER 20 MG TABLET.
Who manufactures ACID REDUCER 20 MG TABLET?
ACID REDUCER 20 MG TABLET (NDC 70000071001) is labeled by Cardinal Health, and CMS classifies it as a generic product.